New Drug for Blood Cancers Now in Five Phase II Clinical Trials
Health & BehaviorResearchers at University of California, San Diego School of Medicine have established the safety and dosing of a new drug for treating blood cancers. The findings are published online July 27 in The Lancet Haematology.